SCHEMBL25366175

SCHEMBL25366175

CCCCNc1ccccc1CN

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 3/20 0.47
POLB P06746 1/20 0.45
TLR7 Q9NYK1 1/20 0.44
CYP1A2 P05177 2/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
HTT P42858 3/20 0.40
UTS2R Q9UKP6 1/20 0.40
LMNA P02545 1/20 0.40
CYP2D6 P10635 1/20 0.40
MAPT P10636 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
KAT2B Q92831 2/20 0.39
KDM4E B2RXH2 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
APAF1 O14727 1/20 0.39
ALDH1A1 P00352 1/20 0.39
BCHE P06276 1/20 0.38
TRPC3 Q13507 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24450630 0.89 IDO1 (0.44) TLR8POLBHTTMAPTKAT2B
SCHEMBL3966040 0.85 POLB (0.60) TLR8POLBCYP1A2CYP3A4CYP2C9
SCHEMBL27918676 0.84 MAPT (0.48) HTTMAPTKAT2BALDH1A1AOC1
SCHEMBL10408180 0.83 POLB (0.46) TLR8POLBCYP1A2CYP3A4CYP2C9
SCHEMBL309485 0.82 TLR8 (0.53) TLR8POLBCYP1A2CYP3A4CYP2C9
SCHEMBL6027445 0.81 POLB (0.49) TLR8POLBTLR7CYP1A2CYP3A4
SCHEMBL6637583 0.80 AOC1 (0.55) POLBHTTMAPTKAT2BALDH1A1
SCHEMBL10407866 0.79 POLB (0.54) TLR8POLBCYP1A2CYP3A4CYP2C9
SCHEMBL20917753 0.79 POLB (0.43) TLR8POLBCYP1A2CYP3A4CYP2C9
SCHEMBL5605579 0.79 LMNA (0.62) TLR8POLBTLR7CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240018125-A1 CYCLIC ISOTHIOUREA DERIVATIVES AS CXCR4 MODULATORS ERMIUM THERAPEUTICS (FR) 2024-01-18 US disclosed
CN-116568675-A Cyclic isothiourea derivatives as CXCR4 modulators 埃尔米乌治疗公司 2023-08-08 CN disclosed
EP-4217353-A1 CYCLIC ISOTHIOUREA DERIVATIVES AS CXCR4 MODULATORS Ermium Therapeutics (FR) 2023-08-02 EP disclosed
WO-2022064075-A1 CYCLIC ISOTHIOUREA DERIVATIVES AS CXCR4 MODULATORS ERMIUM THERAPEUTICS (FR) 2022-03-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240018125-A1 CYCLIC ISOTHIOUREA DERIVATIVES AS CXCR4 MODULATORS CXCR4, CXCR1, CXCL12 TLR8 61/4885POLB 2906/4885TLR7 41/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.